
    <rss version="2.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd">
      <channel>
        <title>Latest articles from PMD</title>
        <link>http://www.pmdcentral.com</link>
        <description>Latest articles from PMD</description>
        <itunes:author>PMD</itunes:author>
        <itunes:subtitle>Home</itunes:subtitle>
        <itunes:summary>Welcome to PMDcentral, a site devoted to healthcare and pharmaceutical marketing. The Pharmaceutical Marketers Directory includes just 

about everything a marketer needs to know about the healthcare industry -- all in one place and all up-to-date. The PMD is a virtual Who's Who in the 

healthcare field and is filled with valuable information on over 5,000 companies and 15,000 executives. PMD is the healthcare business directory of choice when you need to find pharmaceutical marketing managers, pharmaceutical executives, brand managers and agency executives.</itunes:summary>
        <itunes:owner>
            <itunes:name>Home</itunes:name>
            <itunes:email>Admin@haymarketmedia.com</itunes:email>
        </itunes:owner>
        <itunes:category text="BUSINESS">
            <itunes:category text="BUSINESS NEWS" /> 
        </itunes:category> 
        <itunes:image href='http://media.haymarketmedia.com/images/32/MMM_logo_28402_31022.gif'></itunes:image>
        <itunes:explicit>no</itunes:explicit>
  
        <item>
          <title>Taiho Pharmaceutical Announces Results of Randomized Phase II Clinical Trial with Novel Antitumor Agent TAS-102</title>
          <description>Positive Results of Overall Survival in Patients with Colorectal Cancer Refractory to Standard Chemotherapy</description>
          <link>http://www.pmdcentral.com/taiho-pharmaceutical-announces-results-of-randomized-phase-ii-clinical-trial-with-novel-antitumor-agent-tas-102/article/208103/</link>
          <pubDate>Fri, 22 Jul 2011 07:00:00 GMT</pubDate>
          <itunes:summary>Positive Results of Overall Survival in Patients with Colorectal Cancer Refractory to Standard Chemotherapy</itunes:summary>
          <itunes:author>PMD</itunes:author>
          
        </item>
  
        <item>
          <title>Bristol-Myers Squibb to Acquire Amira Pharmaceuticals</title>
          <description>Acquisition Marks Bristol-Myers Squibb&apos;s Entrance into Fibrotic Diseases</description>
          <link>http://www.pmdcentral.com/bristol-myers-squibb-to-acquire-amira-pharmaceuticals/article/208104/</link>
          <pubDate>Thu, 21 Jul 2011 22:48:00 GMT</pubDate>
          <itunes:summary>Acquisition Marks Bristol-Myers Squibb&apos;s Entrance into Fibrotic Diseases</itunes:summary>
          <itunes:author>PMD</itunes:author>
          
        </item>
  
        <item>
          <title>Company News: Express Scripts, Medco, Roche, Eli Lilly</title>
          <description>Pharmacy benefit manager (PBM) Express Scripts said it plans to buy rival Medco Health Solutions, currently the largest PBM, for $29.1 billion.</description>
          <link>http://www.pmdcentral.com/company-news-express-scripts-medco-roche-eli-lilly/article/208046/</link>
          <pubDate>Thu, 21 Jul 2011 19:53:36 GMT</pubDate>
          <itunes:summary>Pharmacy benefit manager (PBM) Express Scripts said it plans to buy rival Medco Health Solutions, currently the largest PBM, for $29.1 billion.</itunes:summary>
          <itunes:author>PMD</itunes:author>
          
        </item>
  
        <item>
          <title>Brilinta boosts AstraZeneca, but can it carry them over the cliff?</title>
          <description>The FDA gave the green light to AstraZeneca&apos;s Brilinta (ticagrelor) anti-platelet for heart attack prevention, but the brand will carry a black box warning, a Risk Evaluation and Mitigation Strategy requirement and an obligation to educate doctors about possible risks of use in users of high-dose aspirin.</description>
          <link>http://www.pmdcentral.com/brilinta-boosts-astrazeneca-but-can-it-carry-them-over-the-cliff/article/208044/</link>
          <pubDate>Thu, 21 Jul 2011 19:41:26 GMT</pubDate>
          <itunes:summary>The FDA gave the green light to AstraZeneca&apos;s Brilinta (ticagrelor) anti-platelet for heart attack prevention, but the brand will carry a black box warning, a Risk Evaluation and Mitigation Strategy requirement and an obligation to educate doctors about possible risks of use in users of high-dose aspirin.</itunes:summary>
          <itunes:author>PMD</itunes:author>
          
        </item>
  
        <item>
          <title>Did a PR firm&apos;s lapse give hackers keys to Pfizer Facebook page?</title>
          <description>Contrary to reports, hackers&apos; brief takeover of the Pfizer Facebook page was probably not due to a security lapse by the social networking giant, security experts say.</description>
          <link>http://www.pmdcentral.com/did-a-pr-firms-lapse-give-hackers-keys-to-pfizer-facebook-page/article/208032/</link>
          <pubDate>Thu, 21 Jul 2011 18:30:37 GMT</pubDate>
          <itunes:summary>Contrary to reports, hackers&apos; brief takeover of the Pfizer Facebook page was probably not due to a security lapse by the social networking giant, security experts say.</itunes:summary>
          <itunes:author>PMD</itunes:author>
          
        </item>
  
        <item>
          <title>FDA Approves New Medicine BRILINTA (Ticagrelor) for Use in the U.S.</title>
          <description>BRILINTA is Now Approved in 39 Countries</description>
          <link>http://www.pmdcentral.com/fda-approves-new-medicine-brilinta-ticagrelor-for-use-in-the-us/article/208105/</link>
          <pubDate>Thu, 21 Jul 2011 02:16:00 GMT</pubDate>
          <itunes:summary>BRILINTA is Now Approved in 39 Countries</itunes:summary>
          <itunes:author>PMD</itunes:author>
          
        </item>
  
        <item>
          <title>Ethnically insensitive Summer&apos;s Eve ads draw eyeballs and brickbats</title>
          <description>A feminine hygiene brand known for its boffo advertising is back with an anatomically-explicit ad campaign that&apos;s generating tons of publicity but also charges of racism.</description>
          <link>http://www.pmdcentral.com/ethnically-insensitive-summers-eve-ads-draw-eyeballs-and-brickbats/article/207975/</link>
          <pubDate>Wed, 20 Jul 2011 19:57:30 GMT</pubDate>
          <itunes:summary>A feminine hygiene brand known for its boffo advertising is back with an anatomically-explicit ad campaign that&apos;s generating tons of publicity but also charges of racism.</itunes:summary>
          <itunes:author>PMD</itunes:author>
          
        </item>
  
        <item>
          <title>Janssen launches HIV awareness campaign with celeb designer David Bromstad</title>
          <description>Janssen Therapeutics, Division of Janssen Products LP, has teamed up with celebrity reality television designer David Bromstad, host of HGTV&apos;s Color Splash and winner of HGTV&apos;s first season of Design Star, to launch an HIV awareness campaign to encourage testing for the condition, called Know Yourself: Get HIV Tested.</description>
          <link>http://www.pmdcentral.com/janssen-launches-hiv-awareness-campaign-with-celeb-designer-david-bromstad/article/207939/</link>
          <pubDate>Wed, 20 Jul 2011 17:56:50 GMT</pubDate>
          <itunes:summary>Janssen Therapeutics, Division of Janssen Products LP, has teamed up with celebrity reality television designer David Bromstad, host of HGTV&apos;s Color Splash and winner of HGTV&apos;s first season of Design Star, to launch an HIV awareness campaign to encourage testing for the condition, called Know Yourself: Get HIV Tested.</itunes:summary>
          <itunes:author>PMD</itunes:author>
          
        </item>
  
        <item>
          <title>FDA guidance exempts most pharma apps from scrutiny</title>
          <description>FDA issued draft guidance on mobile medical apps, focusing narrowly on those programs that augment regulated medical devices or turn mobile devices into medical devices.</description>
          <link>http://www.pmdcentral.com/fda-guidance-exempts-most-pharma-apps-from-scrutiny/article/207847/</link>
          <pubDate>Tue, 19 Jul 2011 19:36:22 GMT</pubDate>
          <itunes:summary>FDA issued draft guidance on mobile medical apps, focusing narrowly on those programs that augment regulated medical devices or turn mobile devices into medical devices.</itunes:summary>
          <itunes:author>PMD</itunes:author>
          
        </item>
  
        <item>
          <title>Company News: Allergan, Vicept Therapeutics and ClinStar </title>
          <description>Global specialty pharma company Allergan has announced plans to acquire privately held dermatology start-up Vicept Therapeutics.</description>
          <link>http://www.pmdcentral.com/company-news-allergan-vicept-therapeutics-and-clinstar/article/207844/</link>
          <pubDate>Tue, 19 Jul 2011 19:23:13 GMT</pubDate>
          <itunes:summary>Global specialty pharma company Allergan has announced plans to acquire privately held dermatology start-up Vicept Therapeutics.</itunes:summary>
          <itunes:author>PMD</itunes:author>
          
        </item>
  
        <item>
          <title>25th Annual Career &amp; Salary Survey under way</title>
          <description>Take the 25th annual MM&amp;M Career &amp; Salary Survey and help us provide you and the rest of the industry with the most accurate and meaningful picture of salaries, aspirations, motivational factors, job satisfaction and HR trends in the healthcare market. All respondents will be entered into a draw to win one of three $150 AmEx gift cards.</description>
          <link>http://www.pmdcentral.com/25th-annual-career-salary-survey-under-way/article/207829/</link>
          <pubDate>Tue, 19 Jul 2011 15:41:53 GMT</pubDate>
          <itunes:summary>Take the 25th annual MM&amp;M Career &amp; Salary Survey and help us provide you and the rest of the industry with the most accurate and meaningful picture of salaries, aspirations, motivational factors, job satisfaction and HR trends in the healthcare market. All respondents will be entered into a draw to win one of three $150 AmEx gift cards.</itunes:summary>
          <itunes:author>PMD</itunes:author>
          
        </item>
  
        <item>
          <title>Calif. office gives Heartbeat a place for conflicts</title>
          <description>Parent company Drumbeat Digital has formally announced the opening of a full-service Los Angeles office, Heartbeat West.</description>
          <link>http://www.pmdcentral.com/calif-office-gives-heartbeat-a-place-for-conflicts/article/207821/</link>
          <pubDate>Tue, 19 Jul 2011 15:14:39 GMT</pubDate>
          <itunes:summary>Parent company Drumbeat Digital has formally announced the opening of a full-service Los Angeles office, Heartbeat West.</itunes:summary>
          <itunes:author>PMD</itunes:author>
          
        </item>
  
        <item>
          <title>Sermo develops real-time medical mobile app for docs</title>
          <description>Online physician community Sermo has launched a free medical app for its exclusive network of more than 120,000 physicians - called Sermo Mobile - which allows doctors to access medical information in real-time.</description>
          <link>http://www.pmdcentral.com/sermo-develops-real-time-medical-mobile-app-for-docs/article/207655/</link>
          <pubDate>Fri, 15 Jul 2011 19:29:14 GMT</pubDate>
          <itunes:summary>Online physician community Sermo has launched a free medical app for its exclusive network of more than 120,000 physicians - called Sermo Mobile - which allows doctors to access medical information in real-time.</itunes:summary>
          <itunes:author>PMD</itunes:author>
          
        </item>
  
      </channel>
    </rss>  
  